ARWR fund manager activity
Arrowhead Pharmaceuticals, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2018 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 957,691 | $78,061,392 | 0.02% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 6,696 | $545,791 | 0.00% | Aug 14, 2026 |
| Polen Capital Management | New | 6,612 | $538,944 | 0.00% | Aug 4, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 1,113,568 | $69,820,712 | 0.02% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 38,168 | $2,393,134 | 0.01% | May 15, 2026 |